Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-08-28

Clinical Trial Update: Effects of Exogenous Ketone Ester Supplementation on 3-hydroxybutyrate Concentrations in Human Cerebrospinal Fluid [NA]

View source ↗

Summary

A completed clinical trial assessing whether taking exogenous ketone esters affects 3-hydroxybutyrate levels in human cerebrospinal fluid in ketosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Exogenous ketone ester (ketone ester)

Snippet

Sponsor: University of Aarhus | Conditions: Ketosis | NA | Status: COMPLETED